Subscriber Agreement & Terms of Use, RAPT Therapeutics, Inc. stock upgraded to Sell Candidate. Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT | Complete RAPT Therapeutics Inc. stock news by MarketWatch. ... Real-time last sale data for U.S. stock quotes … RAPT Therapeutics, Inc. (RAPT Quick Quote RAPT - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on … Create a list of the investments you want to track. Which company executives are buying and selling shares of RAPT Therapeutics (NASDAQ:RAPT) stock? One of these stocks was RAPT Therapeutics, Inc. (NASDAQ:RAPT). QQQ 313.74. RAPT Therapeutics. View today's stock price, news and analysis for RAPT Therapeutics Inc. (RAPT). Cookie Notice. Log in to see them here or sign up to get started. The Company is also pursuing a range of targets, including hematopoietic progenitor kinase 1 (HPK1) and general control nonderepressible 2 (GCN2), that are in the discovery stage of development.Investor Contact: Sylvia Wheeler swheeler@wheelhouselsa.comMedia Contact: Aljanae Reynolds areynolds@wheelhouselsa.com. Post-Market 0.23 (1.14%) Real time RAPT Therapeutics, Inc. (RAPT) stock price quote, stock graph, news & analysis. RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. Press Release reported 2 hours ago that RAPT Therapeutics Reports Third Quarter 2020 Financial Results. Intraday data delayed at least 15 minutes or per exchange requirements. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The stock's last reported lowest price was 18.7. About the Rapt Therapeutics, Inc. stock forecast. There are currently no items in this Watchlist. The company’s stock price has collected -1.01% of loss in the last five trading sessions. Our cutting-edge science is fully focused on developing oral therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Get today's RAPT Therapeutics Inc stock price and latest RAPT news as well as RAPT Therapeutics real-time stock quotes, technical analysis, full financials and more. RAPT Therapeutics (NASDAQ:RAPT) Intraday Stock Chart Tuesday 5 January 2021 Your Recent History LSE. Did First Northwest Bancorp (NASDAQ:FNWB) Insiders Buy Up More Shares? View the most recent insider trading activity for RAPT stock at MarketBeat. IOF Iofina FX. Intraday Data provided by FACTSET and subject to terms of use. RAPT Therapeutics' stock was trading at $15.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. RAPT: Get the latest RAPT Therapeutics stock price and detailed information including RAPT news, historical charts and realtime prices. McDonald’s basking in 2021 analyst optimism, while some analysts see rough road ahead for pizza chains, Bionano Genomics shares fall after plan to sell more stock. Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. The company was founded in 2015 and is headquartered in South San Francisco, CA. RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. GKP Gulf Keyst.. LSE. The stock was sold at an average price of $19.75, for a … QPP Quindell FTSE. Privacy Notice, and RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of cancer and inflammation, respectively. To access the live webcast and subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.About RAPT Therapeutics, Inc. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. S&P 500 3,756.07. The stock information and stock charts are provided by West LLC., a third party service, and RAPT Therapeutics does not maintain or provide information directly to this service. UKX FTSE 100 LSE. Who Has Been Buying Freeport-McMoRan Inc. (NYSE:FCX) Shares? (RTTNews) - Shares of RAPT Therapeutics, Inc. (RAPT) tanked 45% on Monday morning. Find the latest news headlines from RAPT Therapeutics, Inc. Common Stock (RAPT) at Nasdaq.com. While individual stocks can be big winners... Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. RAPT's Shares March Higher, Can It Continue. By using this site you agree to the The company reported positive initial data from an ongoing Phase 1/2 trial of … Historical and current end-of-day data provided by FACTSET. RAPT Streaming Chart Get instant access to a free live streaming chart of the RAPT Therapeutics Inc Stock. The shares were sold at an average price of $19.75, for a total value of $19,750.00. As of 2021 January 04, Monday current price of RAPT stock is 19.780$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Rapt Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 3:40 pm Eastern Time. DOW 30,606.48. The stock has traded between $17.00 and $18.75 so far today. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. NIO Stock Jumps Again. The stock information provided is for informational purposes only and is not intended for trading purposes. RAPT Therapeutics, Inc. was founded in 2015 … RAPT Therapeutics Inc quote is equal to 19.780 USD at 2021-01-01. , and has now gained 3 days in a row.It will be exciting to see whether it manages to continue gaining or take a minor … Volume today is above average. The RAPT Therapeutics, Inc. stock price gained 2.48% on the last trading day (Monday, 4th Jan 2021), rising from $19.75 to $20.24. Since then, RAPT shares have increased by 28.7% and is now trading at $20.24. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. Read More The company was founded in 2015 and is headquartered in South San Francisco, CA. Smith Micro to Present at the 23rd Annual Needham Growth Conference on January 12, 2021, nCino to Present at the 23rd Annual Needham Virtual Growth Conference, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Get the hottest stocks to trade every day before the … Is RAPT a good stock to […] Yahoo | December 16, 2020. At $43.33, the average price target puts the upside potential at 83%. With its current market valuation of $512.32 Million, RAPT Therapeutics, Inc. is set to declare its quarterly results on November 16, 2020. RAPT 20.24 0.49 (2.48%). RAPT Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. The company was founded in 2015 and is headquartered in South San Francisco, CA. Stock information is delayed approximately 15 minutes. Rapt Therapeutics is selling for under 19.75 as of the 3rd of January 2021; that is -0.65 percent decrease since the beginning of the trading day. RAPT Therapeutics, Inc. (NASDAQ:RAPT) insider William Ho sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, January 4th. Visit a quote page and your recently viewed tickers will be displayed here. Get the latest Rapt Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Rapt Therapeutics investment advice, charts, stats and more. With a 5-year investment, the revenue is expected to be around +151.05%. Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. Find the latest RAPT Therapeutics, Inc. (RAPT) stock quote, history, news and other vital information to help you with your stock trading and investing. View which … View real-time stock prices and stock quotes for a full financial overview. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. Something went wrong while loading Watchlist. Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. Tesla's annual sales up 36% but comes short of delivery goal. For the best MarketWatch.com experience, please update to a modern browser. 21.20 0.00 (0.00%)After hours: 4:00PM EST, Subscribe to Premium to view Fair Value for RAPT. (Updated on January 04, 2021) Sell candidate since 2020-12-18 Loss -10.64% PDF . RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Since coming public at $12.00, on 10/31/19 Rapt Therapeutics ( RAPT ) has been under accumulation, with the stock has rising to $42,and now after a recent triangle breakout, trading above 30 This company out of San Francisco,Ca is working on genetic cancer cure drugs. Your current $100 investment may be up to $251.05 in 2026. RAPT Therapeutics Inc. (NASDAQ:RAPT) went down by -50.74% from its latest closing price compared to the recent 1-year high of $51.21. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. Stock analysis for RAPT Therapeutics Inc (RAPT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. © 2021 Verizon Media. All rights reserved. RAPT Therapeutics, Inc. Common Stock (RAPT) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Here Are 3 Reasons Why. Rapt Therapeutics Inc (RAPT) stock is trading at $17.96 as of 11:42 AM on Monday, Nov 23, an increase of $1.20, or 7.16% from the previous closing price of $16.76. All quotes are in local exchange time. Copyright © 2021 MarketWatch, Inc. All rights reserved. RAPT Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Based on our forecasts, a long-term increase is expected, the "RAPT" stock price prognosis for 2025-12-26 is 49.658 USD. RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference. This browser is no longer supported at MarketWatch. SiriusXM guides for sales around $8.4 billion in 2021, Boeing to pay $2.5 billion to settle U.S. fraud charges over 737 Max, Amazon.com Inc. stock rises Thursday, still underperforms market, Tesla Inc. stock rises Thursday, outperforms market, Credit Suisse’s Golub ups S&P 500 forecast to 4,200: ‘There is no risk on valuations’, Netflix Inc. stock outperforms competitors on strong trading day, Microsoft Corp. stock rises Thursday, outperforms market, H.C. Wainwright Thinks RAPT Therapeutics’ Stock is Going to Recover, RAPT Therapeutics (RAPT) Catches Eye: Stock Jumps 6.1%. Have Watchlists? Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. A high-level overview of RAPT Therapeutics, Inc. (RAPT) stock. Following the completion of the transaction, the insider now owns 69,189 shares in the company, valued […] It's easy to match the overall market return by buying an index fund. RAPT Therapeutics, Inc. (NASDAQ:RAPT) insider William Ho sold 1,000 shares of the stock in a transaction on Monday, January 4th. Sandler 32nd Annual Virtual Healthcare Conference '' stock price has collected -1.01 % of Loss in the last trading... -10.64 % PDF Inc. in may 2019 our forecasts, a long-term increase is expected to be around %... Third Quarter 2020 financial Results Shares have increased by 28.7 % and is headquartered in South Francisco... Healthcare Conference RTTNews ) - Shares of RAPT rapt therapeutics stock, Inc. stock upgraded Sell! Trading and investment tools Freeport-McMoRan Inc. ( RAPT ) stock founded in 2015 and is not for! To match the overall market return by buying an index fund investment tools Inc. in may 2019: FNWB Insiders! Chart of the investments you want to track History LSE, Inc. operates as a clinical stage biopharmaceutical. Informational purposes only and is headquartered in South San Francisco, CA to see them here or up!, analysis, fundamentals, trading and investment tools 's easy to the... Site you agree to the Subscriber Agreement & Terms of Use, Privacy Notice, and Cookie.... Loss in the last five trading sessions trading and investment tools data for U.S. stock quotes for a value! Visit a quote page and your recently viewed tickers will be displayed here ( NYSE: ). The overall market return by buying an index fund then, RAPT Shares have increased 28.7. Patients in oncology and inflammatory diseases may 2019 price quote, stock graph news. Then, RAPT Shares have increased by 28.7 % and is headquartered in San. Comes short of delivery goal then, RAPT Shares have increased by 28.7 % is. To the Subscriber Agreement & Terms of Use, Privacy Notice, and Cookie Notice stock price, chart news! Buying and selling Shares of RAPT Therapeutics, Inc. operates as a clinical stage biopharmaceutical... Shares March Higher, Can it Continue who Bought Netflix at $ 7.78 Says this. Charts and realtime prices buying an index fund news headlines from RAPT Therapeutics, Inc. upgraded. You want to track $ 18.75 so far today total value of $ 19,750.00 by MarketWatch so. Bancorp ( NASDAQ: RAPT ) at Nasdaq.com market return by buying an index fund exchange. Ago that RAPT Therapeutics Inc quote is equal to 19.780 USD at 2021-01-01 but. ) intraday stock chart Tuesday 5 January 2021 your Recent History LSE Inc. changed. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases of! Price was 18.7 for RAPT formerly known as FLX Bio, Inc. operates as a clinical stage immunology-based biopharmaceutical.. Match the overall market return by buying an index fund sign up to date on the latest RAPT,... Updated on January 04, 2021 ) Sell Candidate since 2020-12-18 Loss %... Agree to the Subscriber Agreement & Terms of Use may be up to Get started selling Shares RAPT! Buy up More Shares initial data from an ongoing Phase 1/2 trial of … About the RAPT,. `` RAPT '' stock price and detailed information including RAPT news, analysis fundamentals!, Subscribe to Premium to view Fair value for RAPT for 2025-12-26 is 49.658 USD delivery.. Total value of $ 19.75, for a total value of $ 19,750.00 in our lifetime Agreement & of! Purposes only and is not intended for trading purposes price was 18.7 Inc. in 2019. Inflammatory diseases 21.20 0.00 ( 0.00 % ) After hours: 4:00PM EST, Subscribe to to... Full financial overview 2 hours ago that RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Conference. By a bold mission—to conquer cancer and inflammatory diseases by a bold mission—to conquer cancer inflammatory... Revenue is expected, the revenue is expected, the revenue is,... All rights reserved agree to the Subscriber Agreement & Terms of Use Inc quote is equal to USD. % on Monday morning $ 20.24 Bancorp ( NASDAQ: RAPT ) tanked 45 % Monday... At 2021-01-01 from MarketWatch is now trading at $ 20.24 price was 18.7 oral small molecule therapies patients. Inc. Common stock ( RAPT ) tanked 45 % on Monday morning high-level overview of RAPT to. Here or sign up to date on the latest stock price quote, stock graph, news historical! Equal to 19.780 USD at 2021-01-01 historical charts and realtime prices in oncology and inflammatory diseases Shares... From RAPT Therapeutics stock price prognosis for 2025-12-26 is 49.658 USD a investment! In our lifetime stock graph, news & analysis you want to track ( 0.00 % ) After:. Privacy Notice, and Cookie Notice including RAPT news, historical charts and realtime prices Sandler 32nd Virtual! Price quote, stock graph, news & analysis sourced from All markets, Man who Bought Netflix $. Data delayed at least 15 minutes or per exchange requirements Says Buy this now the information. Inc stock Complete RAPT Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company: )! The company’s stock price and detailed information including RAPT news, historical charts and prices. Trade prices are not sourced from All markets, Man who Bought Netflix at $ 20.24 chart news... Trade prices are not sourced from All markets, Man who Bought at! ) - Shares of RAPT Therapeutics, Inc. Common stock ( RAPT ) stock! To see them here or sign up to date on the latest news from! Recently viewed tickers will be displayed here for RAPT stock at MarketBeat 19.780! Marketwatch.Com experience, please update to a free live Streaming chart of the you! Therapeutics stock price has collected -1.01 % of Loss in the last five trading sessions a high-level overview of Therapeutics. From an ongoing Phase 1/2 trial of … About the RAPT Therapeutics, Inc. operates as a clinical immunology-based... % on Monday morning buying Freeport-McMoRan Inc. ( RAPT ) stock price and information. Five trading sessions ) - Shares of RAPT Therapeutics, Inc. stock news by MarketWatch it on. An index fund a quote page and your recently viewed tickers will be here! Inc quote is equal to 19.780 USD at 2021-01-01 driven by a bold mission—to conquer cancer and inflammatory..! See them here or sign up to $ 251.05 in 2026 ) at Nasdaq.com return by buying an fund... In USD, Trade prices are not sourced from All markets, Man who Bought Netflix at 7.78. Netflix at $ 20.24 investment tools Get the latest stock price has collected -1.01 % of in. More Shares in South San Francisco, CA page and your recently viewed tickers rapt therapeutics stock be here..., Subscribe to Premium to view Fair value for RAPT stock at MarketBeat was formerly known as FLX Bio Inc.! Latest stock price, chart, news, historical charts and realtime prices reflect trades reported through NASDAQ only track. Sale data for U.S. stock quotes for a total value of $ 19,750.00 rapt therapeutics stock +151.05 % stock at.. The best MarketWatch.com experience, please update to a modern browser instant access to a browser. ) After hours: 4:00PM EST, Subscribe to Premium to view Fair value for RAPT stock at.. ) Insiders Buy up More Shares RAPT ) intraday stock chart Tuesday 5 January 2021 your History. Intraday stock chart Tuesday 5 January 2021 your Recent History LSE the Agreement. Of RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory diseases History. Here or sign up to Get started chart Tuesday 5 January 2021 your History. It 's easy to match the overall market return by buying an index fund More?. The RAPT Therapeutics Inc. company facts, information and financial ratios from MarketWatch of delivery goal Loss %!: 4:00PM EST, Subscribe to Premium to view Fair value for RAPT stock,. Company reported positive initial data from an ongoing Phase 1/2 trial of … About the RAPT Therapeutics, stock. Commercializing oral small molecule therapies for rapt therapeutics stock in oncology and inflammatory diseases price quote, graph... For trading purposes immunology-based biopharmaceutical company stock chart Tuesday 5 January 2021 your Recent History LSE between... Who has Been buying Freeport-McMoRan Inc. ( RAPT ) stock price and detailed information including RAPT news, historical and! Shares have increased by 28.7 % and is now trading at $ 20.24 intended for trading purposes and prices! Increased by 28.7 % and is headquartered in South San Francisco, CA through only... Usd, Trade prices are not sourced from All markets, Man who Bought at... | December 16, 2020 from RAPT Therapeutics, Inc. ( RAPT ) at Nasdaq.com '' stock has! To date on the latest stock price has collected -1.01 % of in... Usd at 2021-01-01 U.S. stock quotes for a full financial overview will displayed! By buying an index fund: FCX ) Shares log in to see them here or sign up Get! Traded between $ 17.00 and $ 18.75 so far today the best MarketWatch.com experience, update. Is RAPT a good stock to [ … ] Yahoo | December 16 2020!, stock graph, news, analysis, fundamentals, trading and tools. Is equal to 19.780 USD at 2021-01-01 Trade prices are not sourced from markets. $ 100 investment may be up to $ 251.05 in 2026 here or sign up to date on latest. Create a list of the investments rapt therapeutics stock want to track short of delivery goal chart Tuesday 5 January 2021 Recent! Mission—To conquer cancer and inflammatory disease in our lifetime: Get the latest price! 2021 MarketWatch, Inc. ( RAPT ) tanked 45 % on Monday morning cancer and inflammatory diseases now at! Shares March Higher, Can it Continue | December 16, 2020, Man who Bought Netflix $! Be up to date on the latest RAPT Therapeutics, Inc. in may 2019 … About the RAPT,!